Facebook
Twitter
LinkedIn
Forward
2023 James Horner DVP - SPRINT Ahead
Target Audience
- Internal Medicine Physicians
- Family Medicine Physicians
- Nurse Practitioners
- Pharmacists
- Physician Assistants
- Residents/Fellows
- Nurses
- Medical Students
Learning Objectives
- Describe the various guidelines for the diagnosis and treatment of hypertension
- Identify the importance of lifestyle factors in managing and controlling hypertension
- Define the first, second, and subsequent line treatment options for patients with hypertension
DESIRED OUTCOME
This lecture is designed to provide interactive educational activities that discuss complicated case scenarios that have been shown to improve participant application of evidence based medicine for patients with hypertension. Providing a format for adult learning that includes lectures, case-based studies, an interactive question and answer session, collaborative sharing of patient care issues, and networking with other healthcare professionals has shown to improve participant knowledge and competency.
PROFESSIONAL PRACTICE GAP
Hypertension is a significant cause of morbidity and mortality and a major risk factor for cardiovascular disease as well as stroke, end-stage renal failure, and peripheral vascular disease. According to the Centers for Disease Control and Prevention (CDC) nearly half of the adults in the United States have hypertension (48.1%, 119.9 million), defined as a systolic blood pressure greater than 130 mmHg or a diagnostic blood pressure greater than 80 mmHg or are taking medication for hypertension. Also, hypertension is associated with shorter life expectancy. Over the last decade, there have been numerous updates in the treatment of patients with hypertension. Our target audience’s current professional practice is less than ideal or could be better in terms of its knowledge and competence in the methodologies to reduce elevated blood pressure that results in improved patient outcomes. Clinical inertia can also be an issue if healthcare providers fail to initiate or intensify antihypertensive therapy when indicated. However, disparities in the treatment of hypertension still exist. This lecture is designed to give healthcare professionals the latest evidence-based medicine that could be utilized in clinical practice for the prevention and management of hypertension in patients.
Additional Information
| Attachment | Size |
|---|---|
 2023 Horner Brochure | 1.15 MB |
*** This live activity has been approved for up to 3 AMA PRA Category 1 CreditsTM. There will not be an option for remote attendance.****
| James H. Horner, MD DVP Lecture - SPRINT Ahead - An Update in Hypertension | Friday, September 22, 2023 | |
| Agenda | ||
| Timeslot | Presentation | Presenter |
| 11:30 AM - 12:25 PM | Lunch | |
| 12:25 PM - 12:30 PM | Introduction / Opening Remarks | Karen C. Johnson, MD, MPH |
| 12:30 PM - 1:30 PM | BP Control in the Post SPRINT Era | Jackson T. Wright, MD, PhD |
| 1:30 PM - 2:15 PM | An Update of the Systolic Blood Pressure Intervention Trial (SPRINT) | Karen C. Johnson, MD, MPH |
| 2:15 PM - 3:00 PM | How to Treat Hypertension in the Post SPRINT Era | William Cushman, MD |
| 3:00 PM - 3:30 PM | Panel Discussion (Including all 3 speakers) | |
| 3:30 PM - 3:40 PM | Closing Remarks and Adjournment | Karen C. Johnson, MD, MPH |
| Total CME | 3 hours |
Parking available in the garage beside Hamilton Eye Institute.
2023 James H. Horner Distinguished Visiting Professor
Jackson T. Wright, MD, PhD
Jackson T. Wright, MD, PhD, FACP, FASH, FAHA is Professor of Medicine and Program Director of the William T. Dahms MD Clinical Research Unit at University Hospitals Cleveland Medical Center. Also, he is Director of the Clinical Hypertension Program in the Division of Nephrology and Hypertension. He received both his MD and PhD (Pharmacology) from the University of Pittsburgh. Dr. Wright completed his Internal Medicine residency at the University of Michigan. He is board certified in Internal Medicine and received subspecialty board certification in Clinical Pharmacology.
Dr. Wright’s primary research interest is in the clinical pharmacology of antihypertensive and cholesterol lowering agents, especially in minority populations. He has published extensively in this area (over 300 articles, book chapters, and abstracts) and served on many national and international advisory panels.
Dr. Wright was selected for service on the three latest U.S. national hypertension guideline panels. He co-chaired the treatment section for the previous joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, served on the panel that generated the 2014 U.S. hypertension guideline report, and currently serves on the hypertension guideline panel convened by the American Heart Association and American College of Cardiology.
AMA Credit Designation:
The University of Tennessee College of Medicine (UTCOM) designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education for Non-Physicians:
The UTCOM will issue Certificates of Participation to non-physicians for participating in this activity and designates it for CEUs using the national standard that 1 hour of educational instruction is awarded .1 CEU.
Accreditation:
The UTCOM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education for Pharmacists: The University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Successful completion of this knowledge-based activity will provide a statement for 3.0 contact hours of credit (0.3 CEU). Successfully completing the activity and receiving credit includes: 1) reading the learning objectives and faculty disclosures; 2) participating in the educational activity; 3) evaluating the activity via utcop.learningexpressce.com within 14 days of the scheduled activity date. UAN: 0064-9999-23-095-L01-P.
Available Credit
- 3.00 AMA PRA Category 1 Credit™
- 3.00 Attendance